Êtes-vous un étudiant de l'EPFL à la recherche d'un projet de semestre?
Travaillez avec nous sur des projets en science des données et en visualisation, et déployez votre projet sous forme d'application sur Graph Search.
Protein Engineering, especially protein post-translational modification (PTM), ex-tends proteomes in a more complex way than one can expect from analysis of their encod-ing genomes. It can activate or deactivate certain catalytic functions, add new desired func-tions, or change some biological activity of the protein. In this thesis work, we use protein engineering tools to show that a number of functions can be engineered to improve protein-based therapeutics. First, on melanoma cancer vaccine development, we demonstrated a new and ver-satile nanovaccine platform to address the major challenges in neoantigen cancer vaccine delivery by "polymerizing" the neoepitopes through a reversible polycondensation reaction. Using synthetic long peptide (SLP) bearing a neoepitope and multiple amine groups as one monomer (monomer A) mixed with another reactive bi-functional monomer (monomer B), we prepared a polycondensate neoepitope (PNE) with controlled sizes and responsiveness, which showed superior LN targeting and efficient activation of antigen-presenting cells (APCs). Upon internalization by APCs, redox-responsiveness antigen release facilitated the endosome escape and cytosol delivery of peptide antigens and markedly promoted the cross-presentation, and elicited potent antigen-specific CD8+ T cell responses in immunized mice, therefore, enabling markedly enhanced antitumor efficacy in a prophylactic mouse model. Second, on antivirals development, we demonstrated a protein-based new and ver-satile approach for broad-spectrum virucidal material through a one-step reaction by simply chemically conjugating a long flexible and hydrophobic ligand onto the surface of a protein core. Modified proteins reproducibly showed not only effective antiviral inhibition but also a good virucidal effect. Broad-spectrum antiviral inhibition effect was observed against HSV-2, Influenza H1N1, and SARS-CoV-2. Two important key factors, ligand density, and ligand hydrophobic force, significantly influenced antiviral inhibition and virucidal effect. This protein-based antiviral platform provided an easy-manufactured, versatile, broad-spectrum effective, and potentially translatable antiviral solution. At last, we demonstrated a lipoprotein-cholesterol nanoparticle-based non-invasive cancer diagnosis system. In this preliminary test and proof of concept, lipoprotein-cholesterol nanoparticles were extracted from 5 melanoma cancer patients' serum by a lab-developed simple and reproducible technique with a high yield. This method successfully eliminated the most abundant inert protein serum albumin and accumulated low abundance proteins, which are usually masked by serum albumins. LC-MS/MS proteomic analysis data indicates within a false discovery rate less than 0.05, differentially expressed proteins, either up-or down-regulated proteins with fold-change over 2, were identified and can potentially be used as cancer biomarkers.
Bart Deplancke, Guido Van Mierlo, Jorieke Weiden
,
Francesco Stellacci, Bruno Emanuel Ferreira De Sousa Correia, Pablo Gainza Cirauqui, Corey Alfred Stevens, Francesca Olgiati, Chiara Medaglia, Lukasz Richter